Abstract
It is not unusual to hear or read that the therapeutic effects of beta-adrenoceptive blocking agents (BABAs) upon a variety of cardiovascular disorders - including hypertension - are satisfactorily explained by a preferentially, if not exclusively, peripheral locus of action of these drugs. In other words, one tends to assume that BABAs correct, for example, an abnormally elevated blood pressure by interfering with signal transmission at a variety of peripheral, post- and presynaptically located beta-adrenergic receptor sites. Van Zwieten and Timmermans [63], on the basis of their results obtained with atenolol and metoprolol, were ready to conclude that “a central mechanism (does not) underly the antihypertensive activity of beta-blockers.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andén NE, Dahlstróm A, Fuxe K, Larsson K, Olson L, Ungerstedt U (1966) Ascending monoamine neurons to the telencephalon. Acta Physiol Scand 67: 313–326
Anlezark GM, Crow TJ, Greenway AP (1973) Impaired learning and decreased cortical norepi-nephrine after bilateral locus coeruleus lesions. Science 181: 682–684
Belcher G (1977) Correlation between effects of brain stem stimulation and effects of 5-hydroxytryptamine and noradrenaline on non-nociceptive and nociceptive spinal interneurons. Br J Pharmacol 61: 149P–150 P
Betts TA, Alford C (1985) Beta-blockers and sleep. Eur J Clin Pharmacol 28 [Suppl]: 65–68
Betts TA, Knight R, Crowe A, Blake A, Harvey P, MortiboyD (1985) Effect of beta-blockers on psychomotor performance in normal volunteers. Eur J Clin Pharmacol 28 [Suppl]: 39–49
Burks TF (1972) Central alpha adrenergic receptors in thermoregulation. Neuropharmacology 11: 615–624
Commissiong JW (1981) Spinal monoaminergic systems: an aspect of somatic motor function. Fed Proc40: 2771–2777
CommissiongJW, GalliCL, NeffNH (1978) Differentiation of dopaminergic and noradrenergic neurons in rat spinal cord. J Neurochem30: 1095–1099
Commissiong JW, Gentleman S, Neff NH (1979) Spinal cord dopaminergic neurons: evidence for an increased nigrospinal pathway. Neuropharmacology 18: 565–568
Cove-Smith JR, Kirk CA (1985) CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 28 [Suppl]: 69–72
Dahlstrom A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand62 [Suppl 232]: 1–55
Duggan AW, Headley PM (1977) The effects of noradrenaline and 5-hydroxytryptamine on the responses of dorsal horn neurons to noxious and innocuous skin stimuli. Br J Pharmacol 61: 149 P
Falck B, Hillarp NA, Thieme G, Torp H (1962) Fluorescence of catecholamines and related compounds condensed with formaldehyde. J Histochem Cytochem 10: 348–354
Feldberg W, Myers RD (1964) Effects on temperature of amines injected into the cerebral ventricles. A new concept of temperature regulation. J Physiol (Lond) 173: 226–237
Fields HL, Basbaum AI (1978) Brain stem control of spinal pain-transmission neurons. Annu Rev Physiol 40: 217–248
Foerster EC, Greminger P, Siegenthaler W, Vetter H, Vetter W (1985) Atenolol versus Pindolol: side effects in hypertension. Eur J Clin Pharmacol 28 [Suppl]: 89–91
German DC, Bowden DM (1974) Catecholamine system as the neural substrate for intracranial self-stimulation: a hypothesis. Brain Res 73: 381–419
Gosling RH (1977) Clinical experience with oxprenolol in the treatment of anxiety in the United Kingdom. In: KielholzP (ed) Beta-blockers and the central nervous system. Huber, Bern, pp 125–130
Guyenet PG, Cabot JB (1981) Inhibition of sympathetic preganglionic neurons by catechola-mines and clonidine: mediation by an alpha-adrenergic receptor. J Neurosci 1: 908–917
Harms D (1985) Visual reaction times may be improved by certain beta-blockers. Eur J Clin Pharmacol 28 [Suppl]: 51–54
Hoffer BJ, Siggins GR, Oliver AP, Bloom FE (1973) Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J Pharmacol Exp Ther 184: 553–569
Kleinloge IH, Scholtysik O, Sayers AC (1975) Effects of clonidine and BS100-151 on the EEG sleep pattern in rats. Eur J Pharmacol 33: 159–163
Kielholz P (ed) (1978) A therapeutic approach to the psyche via the beta-adrenergic system. Huber, Bern
Kobayashi RM, Palkovits M, Jabobowitz DM, Kopin IJ (1975) Biochemical mapping of the noradrenergic projection from the locus coeruleus. Neurology 25: 223–233
Koella WP (1977) Anatomical, physiological, and pharmacological findings relevant to the central nervous effects of the beta-blockers. In: KielholzP (ed) Beta-blockers and the central ner-vous system. Huber, Bern, pp 21–34
Koella WP (1978) Central effects of beta-adrenergic blocking agents: mode and mechanisms of action. In: Kielholz P (ed) A therapeutic approach to the psyche via the beta-adrenergic system. Huber, Bern, pp 11–29
Koella WP (1982) A modern neurobiological concept of vigilance. Experientia38: 1426–1437
Koella WP (1984) The organization and regulation of sleep; a review of the experimental evidence and a novel integrated model of the organizing and regulating apparatus. Experientia 40: 309–338
Koella WP (1984) Vigilance - local vigilance - the vigilance profile. A new concept and its application in neurobiology and biological psychiatry. Acta Neurol Scand 69 [Suppl 99]: 35–41
Koella WP (1985) CNS-related (side-)effects of beta-blockers with special reference to mecha-nisms of action. Eur J Clin Pharmacol 28 [Suppl]: 55–63
LaderM (1974) The peripheral and central role of the catecholamines in the mechanisms of anx-iety. Int Pharmacopsychiatry 9: 125–137
Leppávuori A, Putkonen PTS (1980) Alpha-adrenoceptive influences on the control of the sleep- waking cycle in the cat. Brain Res 193: 95–115
Lidbrink P (1974) The effect of lesions of the ascending noradrenaline pathway on sleep and waking in the rat. Brain Res 74: 19 - 40
Liebeskind JG, Guilbaud G, Besson JM, Oliveras JL (1973) Analgesia from electrical stimulation of the periaqueductal gray matter in the cat; behavioral observations and inhibitory effects on spinal cord interneurons. Brain Res 50: 441–446
Livett BG (1973) Histochemical visualization of peripheral and central adrenergic neurones. Br Med Bull 29: 93–103
Loewy AD, NeilJJ (1981) The role of descending monoaminergic systems in central control of blood pressure. Fed Proc40: 2778–2785
Loewy AD, McKellar S, Saper CF (1979) Direct projection from the A5 catecholamine cell group to the intermedio-lateral cell column. Brain Res 174: 309–314
Maeda T, Pin C, Salvert D, Ligier M, Jouvet M (1973) Les neurones contenant des catécholamines du tegmentum pontique et leurs voies de projection chez le chat. Brain Res 57: 119–152
Margules DL (1971) Alpha- and beta-adrenergic receptors in amygdala: reciprocal inhibitors and facilitators of punished operant behaviour. Eur J Pharmacol 16: 21–26
Mason ST, Fibiger HC (1979) Noradrenaline and selective attention. Life Sci25: 1949–1956
Mason ST, Iversen SD (1975) Learning in the absence of forebrain noradrenaline. Nature 258: 422–424
Mason ST, Iversen SD (1979) Theories of the dorsal bundle extinction effect. Brain Res Revi: 107–137
MatsuyamaS, Coinet J, Mouret J (1975) 6-hydroxydopamine intracysternale et sommeil chez le rat. Brain Res 57: 85–95
Mayer DJ, Wolfle TL, Akil H, Carder B, Liebeskind JC (1971) Analgesia from electrical stimulation in the brain stem of the rat. Science 174: 1351–1354
McDevitt DG (1985) Beta-blockers and psychometric performance: studies in normal volunteers. Eur J Clin Pharmacol 28 [Suppl]: 35–38
McLennan PL (1981) The hypothermic effect of clonidine and other imidazolines in relation to their ability to enter the central nervous system in mice. Eur J Pharmacol 69: 477
Middlemiss DN, Buxton DA, Greenwood DT (1981) Betaadrenoceptor antagonists in psychiatry and neurology. Pharmacol Ther 12: 419–437
Moisés HC, Woodward DJ, HofferBJ, FreedmanR (1979) Interactions of norepinephrine with Purkinje cell responses to putative aminoacid neurotransmitters applied by microiontophoresis. Exp Neurol 64: 493–515.
NeumayrRJ, HareRD, Franz DN (1974) Evidence for bulbospinal control of sympathetic pre-ganglionic neurons by monoaminergic pathways. Life Sci 14: 793–806
Noyes R (1982) Beta-blocking drugs and anxiety. Psychosomatics 23: 155–170
Pickel VM, Segal M, Bloom FE (1974) A radioautographic study of the efferent pathways of the nucleus locus coeruleus. J Comp Neurol 155: 15–41
Redmond DE, Huang YH, Snyder DR (1976) Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey, macaca arctoides. Brain Res 116: 502–510
Reis DJ, Weinbren M, Corvelli A (1968) A circadian rhythm of norepinephrine regionally in the cat brain: its relationship to environmental lighting and to regional diurnal variations in brain serotonin. J Pharmacol Exp Ther 164: 135–146
Rudy TA, Wolf HH (1969) Receptor selectivity of the hypothermic response to intracerebrally injected catecholamines in cats. Fed Proc28: 443
Snyder SH (1977) Opiate receptors and internal opiates. Sci Am236: 44–56
Spencer PSJ (1976) Some aspects of the pharmacology of analgesia. J Int Med Res 4 [Suppl 2]: 1–14
Swanson LW, Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamines-hydroxylase as a marker. J Comp Neurol 163: 467–506
Takagi H (1980) The nucleus reticularis paragigantocellularis as a site of analgesic action of morphine and enkephalin. Trends Pharmacol Sci 1: 182–184
TanakaC, InagakiC, FujiwaraH (1976) Labeled noradrenaline release from rat cerebral cortex following electrical stimulation of locus coeruleus. Brain Res 106: 384–389
Taylor DG, Brody MJ (1976) Spinal adrenergic mechanism regulating sympathetic outflow to blood vessels. Circ Res 38 [Suppl 2]: 10–20
Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand [Suppl] 367: 1–29
Van der Laan JW, van Veenendaal W, Voorthuis P, Weick G, Hillen FC (1985) The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour. Eur J Pharmacol 107: 367–373
Van Zwieten PA, Timmermans PBMWM (1985) Brain levels and acute antihypertensive activity of beta-blockers. Eur J Clin Pharmacol 28 [Suppl]: 13–19
Ward DG, Gunn CG (1976) Locus coeruleus complex: differential modulation of depressor mechanisms. Brain Res 107: 407–411
Westerlund A (1985) Central nervous system side-effects with hydrophilic and lipophilic beta- blockers. Eur J Clin Pharmacol 28 [Suppl]: 73–76
Yaksh TL (1978) Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 160: 180–185
Yaksh TL, Hammond DL, Tyce GM (1981) Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information. Fed Proc40: 2786–2794
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Koella, W.P. (1986). Central Nervous Noradrenergic and Adrenergic Systems and their Functions. In: Middeke, M., Holzgreve, H. (eds) New Aspects in Hypertension Adrenoceptors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71418-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-71418-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71420-7
Online ISBN: 978-3-642-71418-4
eBook Packages: Springer Book Archive